U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07060287) titled 'Prognostic Value of miR-21 and miR-486 in Pulmonary Nodule Surgery' on July 02.
Brief Summary: This study prospectively evaluated the prognostic value of microRNA-21 (miR-21) and microRNA-486 (miR-486) expression in patients with pulmonary nodules who underwent clock-guided minimally invasive surgery. The study aimed to determine if high expression levels of these miRNAs in resected nodule tissue correlate with poorer clinical outcomes, including larger residual tumor size, higher metabolic activity, and shorter overall and progression-free survival.
Study Start Date: Jan. 01, 2020
Study Type: OBSERVATIONAL
Condition:
Pulmonary ...